Friends don’t let friends stay on weekly teclistamab forever 😉 Thanks VJHemOnc for showcasing our #EHA2024 #MMsm work in myeloma - claims data with similar results to MSKCC data by Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 et al!

Welcome to Dr. Haley Simpson who will be joining our CU Anschutz Division of Hematology myeloma team as an instructor. cc Daniel Sherbenou, MD, PhD CU Anschutz Hematology/Oncology Fellowship CU Department of Medicine #mmsm

CONGRATS to our 2024-2025 T32 Awardees! Way to go everyone! Thank you to the CU Cancer Center for generously supporting our T32. #BestYouCANB Daniel Sherbenou, MD, PhD Traci Lyons Graduate School

Great thread below; so much interesting data that will take a while to truly comprehend. One takeaway is explanation for the heterogeneity in outcomes w/ 1q gain. I err on the side of calling it a high risk abnormality but upcoming hi risk definition will help to further clarify

Welcome to Jorge Monge, MD who is joining our CU Anschutz Division of Hematology myeloma division! #mmsm cc CU Cancer Center CU Department of Medicine

Practice changing data ! 👏🎊Rahul Banerjee, MD, FACP and team

Our ASH abstract describing a new CD45+LAG-3+ phenotype displayed by myeloma cells persisting after T cell redirection therapies is now live! ash.confex.com/ash/2024/webpr…

Mark your calendar for Alana Keller’s thesis defense next Tuesday! Alana (Keller) Hoey, PhD Daniel Sherbenou, MD, PhD #BestYouCANB

CONGRATS to Dr. Alana Keller Hoey for successfully defending her thesis today! Way to go Dr. Keller Hoey! #BestYouCANB Alana (Keller) Hoey, PhD Daniel Sherbenou, MD, PhD

What amazing rotation talks by our 1st-years! Way to go everyone! #BestYouCANB

Ever wonder what underlies light chain escape in #Myeloma ? - see enclosed 🤯

Our kids’ first grade teacher is a musician-educator genius. You really gotta check him out, this is our new favorite. youtube.com/watch?v=rxOv8L…

Today was special, my friend Leonard stopped by clinic and gave me his entire bow tie collection 🙏 so honored, can’t wait to wear one

Out today in Molecular Cancer Research our study spearheaded by Zachary Walker and Neel Mukherjee landing on a novel combination therapy for Multiple Myeloma - protein translation inhibition + mTOR inhibition aacrjournals.org/mcr/article-ab…

Super exciting approach to improve CART, let’s do this for MM! Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia: Cancer Cell cell.com/cancer-cell/fu…